Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 1 , Pages vii-ix , February 2009

The endocannabinoid system in metabolic control: a preface

References 

  1. Di Marzo V. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia. 2008;51:1356–1367
  2. Matias I, Gonthier MP, Orlando P, et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. The Journal of Clinical Endocrinology and Metabolism. 2006;91:3171–3180
  3. Jones D. End of line for cannabinoid receptor 1 as an anti-obesity target?. Nature Reviews Drug Discovery. 2008;7:961–962
  4. Kunos G, Osei-Hyiaman D, Bátkai S, et al. Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain?. Trends in Pharmacological Sciences. 2008 Nov 28;[Epub ahead of print]
  5. Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce?. Nature Reviews Drug Discovery. 2008;7:438–455

PII: S1521-690X(08)00174-7

doi: 10.1016/j.beem.2008.12.005

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 1 , Pages vii-ix , February 2009

Article Tools